South Korea
· Delayed Price · Currency is KRW Daewoong Pharmaceutical Statistics
Total Valuation
KRX:069620 has a market cap or net worth of KRW 1.79 trillion. The enterprise value is 2.52 trillion.
| Market Cap | 1.79T |
| Enterprise Value | 2.52T |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:069620 has 11.51 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 11.51M |
| Shares Outstanding | 11.51M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.31% |
| Owned by Institutions (%) | 25.42% |
| Float | 5.39M |
Valuation Ratios
The trailing PE ratio is 46.64 and the forward PE ratio is 14.71. KRX:069620's PEG ratio is 0.27.
| PE Ratio | 46.64 |
| Forward PE | 14.71 |
| PS Ratio | 1.24 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 3.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 46.58 |
| PEG Ratio | 0.27 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.88, with an EV/FCF ratio of -25.32.
| EV / Earnings | 65.44 |
| EV / Sales | 1.74 |
| EV / EBITDA | 13.88 |
| EV / EBIT | 19.09 |
| EV / FCF | -25.32 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.75.
| Current Ratio | 1.05 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 3.44 |
| Debt / FCF | -7.05 |
| Interest Coverage | 27.36 |
Financial Efficiency
Return on equity (ROE) is 3.78% and return on invested capital (ROIC) is 6.34%.
| Return on Equity (ROE) | 3.78% |
| Return on Assets (ROA) | 5.08% |
| Return on Invested Capital (ROIC) | 6.34% |
| Return on Capital Employed (ROCE) | 11.03% |
| Revenue Per Employee | 835.78M |
| Profits Per Employee | 22.28M |
| Employee Count | 1,727 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 2.67 |
Taxes
In the past 12 months, KRX:069620 has paid 34.75 billion in taxes.
| Income Tax | 34.75B |
| Effective Tax Rate | 49.67% |
Stock Price Statistics
The stock price has increased by +50.43% in the last 52 weeks. The beta is 0.47, so KRX:069620's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +50.43% |
| 50-Day Moving Average | 139,878.00 |
| 200-Day Moving Average | 136,110.00 |
| Relative Strength Index (RSI) | 56.56 |
| Average Volume (20 Days) | 54,795 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:069620 had revenue of KRW 1.44 trillion and earned 38.48 billion in profits. Earnings per share was 3,344.47.
| Revenue | 1.44T |
| Gross Profit | 745.32B |
| Operating Income | 154.27B |
| Pretax Income | 69.96B |
| Net Income | 38.48B |
| EBITDA | 203.74B |
| EBIT | 154.27B |
| Earnings Per Share (EPS) | 3,344.47 |
Balance Sheet
The company has 102.86 billion in cash and 701.16 billion in debt, giving a net cash position of -598.30 billion or -51,997.69 per share.
| Cash & Cash Equivalents | 102.86B |
| Total Debt | 701.16B |
| Net Cash | -598.30B |
| Net Cash Per Share | -51,997.69 |
| Equity (Book Value) | 929.54B |
| Book Value Per Share | 69,895.67 |
| Working Capital | 31.35B |
Cash Flow
In the last 12 months, operating cash flow was 38.53 billion and capital expenditures -137.99 billion, giving a free cash flow of -99.45 billion.
| Operating Cash Flow | 38.53B |
| Capital Expenditures | -137.99B |
| Free Cash Flow | -99.45B |
| FCF Per Share | -8,643.41 |
Margins
Gross margin is 51.64%, with operating and profit margins of 10.69% and 2.67%.
| Gross Margin | 51.64% |
| Operating Margin | 10.69% |
| Pretax Margin | 4.85% |
| Profit Margin | 2.67% |
| EBITDA Margin | 14.12% |
| EBIT Margin | 10.69% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 600.00, which amounts to a dividend yield of 0.38%.
| Dividend Per Share | 600.00 |
| Dividend Yield | 0.38% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 20.11% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 0.38% |
| Earnings Yield | 2.14% |
| FCF Yield | -5.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2012. It was a forward split with a ratio of 1.03.
| Last Split Date | Dec 27, 2012 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
KRX:069620 has an Altman Z-Score of 2.28 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.28 |
| Piotroski F-Score | 6 |